Sun Pharma Advanced Research Company Limited

Informe acción NSEI:SPARC

Capitalización de mercado: ₹79.3b

Sun Pharma Advanced Research Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Anilkumar Raghavan

Chief Executive Officer (CEO)

₹50.2m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO10yrs
Participación del CEOn/a
Permanencia media de la dirección4.3yrs
Promedio de permanencia en la Junta Directiva9.5yrs

Actualizaciones recientes de la dirección

Recent updates

Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Jan 17
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Nov 14
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Sep 05
Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Jun 27
Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

Nov 23
Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Feb 08
If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

Dec 14
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

CEO

Anilkumar Raghavan (55 yo)

10yrs

Permanencia

₹50,167,000

Compensación

Mr. Anilkumar Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Anilkumar Raghavan
Chief Executive Officer10yrs₹50.17msin datos
Chetan Rajpara
Chief Financial Officer7.2yrs₹15.14msin datos
Siu-Long Yao
Executive Vice President Clinical Development & Operations2.5yrssin datossin datos
Jaydeep Issrani
Senior General Manager of Business Developmentno datasin datossin datos
Shanta Gupta
Chief Human Resource Officer4.3yrssin datossin datos
Nitin Dharmadhikari
Executive VP and Head Operational Excellence & COE'sno datasin datossin datos
Nitin Damle
Executive VP & Chief Innovation Officerno datasin datossin datos
Yashoraj Zala
Senior Vice President of Drug Delivery Systemno datasin datossin datos
Vikram Ramanathan
Senior VP & Head of Translational Development5yrssin datossin datos
Venkata Palle
Executive VP & Global Head of Drug Discovery and Preclinical Development1.1yrssin datossin datos
Kajal Damania
Company Secretaryless than a yearsin datossin datos

4.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de SPARC se considera experimentado (4.3 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Dilip Shanghvi
Chairman18.1yrs₹330.00k19.06%
₹ 15.1b
Sudhir Valia
Non-Executive Director18.1yrs₹690.00k1.84%
₹ 1.5b
Robert Jay Spiegel
Independent Director3.8yrs₹540.00ksin datos
Bhavna Doshi
Independent Director9.5yrs₹630.00ksin datos
Thennati Rajamannar
Non-Executive Non-Independent Director16.8yrs₹360.00k0.011%
₹ 8.7m
Ferzaan Engineer
Independent Director6.9yrs₹540.00ksin datos
Mark Simon
Member of Advisory Board3.3yrs₹570.00ksin datos

9.5yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: La junta directiva de SPARC se considera experimentada (9.5 años de antigüedad promedio).